Arizona State University test RA and OA arthritis patients with OLIVENOL
Clinical Study:
PHOENIX—A scientific human study underway at the Arizona Biodesign Institute at Arizona State University (ASU) is investigating the effects of Olivenol® on rheumatoid arthritis (RA) and osteoarthritis (OA).
Approximately 100 RA and OA patients will be involved in the eight-week study, which will test whether Olivenol can increase mobility and minimize pain by decreasing swelling of the joints and inflammation of the surrounding muscles, tendons and tissues.
CreAgri Inc. is the primary sponsor of the study, and is supplying Olivenol, which contains the active ingredient HIDROX, a rich source of the antioxidant hydroxytyrosol. “We are very pleased and excited by this collaboration with ASU and the Arizona Biodesign Institute,” said Roberto Crea, founder and chief executive officer of CreAgri. “The results of this study could influence the medical community to review Olivenol, and its active ingredient HIDROX, as a potential safe and effective treatment to alleviate the symptoms of RA and OA. It may serve as an alternative or a complement to drugs that are more expensive and have numerous side effects.”
No comments:
Post a Comment